Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Feb 10;10(1):63-72.
doi: 10.1089/trgh.2023.0057. eCollection 2025 Feb.

Intimate Partner Violence Among Brazilian Trans and Cisgender Women Living with HIV or at HIV Risk During COVID-19 Era: Another Epidemic?

Affiliations

Intimate Partner Violence Among Brazilian Trans and Cisgender Women Living with HIV or at HIV Risk During COVID-19 Era: Another Epidemic?

Ricardo de Mattos Russo Rafael et al. Transgend Health. .

Abstract

Purpose: Our study was conducted to estimate intimate partner violence (IPV) prevalence and associated factors among trans and cisgender women at risk of or living with HIV during the coronavirus disease (COVID-19) pandemic in Rio de Janeiro, Brazil.

Methods: A cross-sectional study was conducted between May and August 2020 through telephone surveys with cisgender and trans women enrolled in two cohort studies in Rio de Janeiro. We assessed IPV employing the Revised Conflict Tactics Scale during the initial months of shelter-in-place ordinances. Regression models evaluated the factors associated with IPV for each population.

Results: We surveyed 796 women, and 341 participants (47.78%) were eligible and included in the current analysis. All cisgender women and 41 (64.06%) trans women were living with HIV. Overall IPV prevalence was 27.86% (95% confidence interval [95% CI] 23.34-32.88). IPV was 63% higher among trans women than among cisgender women (prevalence ratio 1.63, 95% CI 1.14-2.34, p=0.008). Loneliness was significantly associated with IPV in both groups. Younger age and binge drinking were associated with IPV prevalence among trans women. For cisgender women, IPV was associated with withdrawal of cash transfer programs during the shelter-in-place.

Conclusion: Trans women experienced significantly more IPV than cisgender women in the early phase of the COVID-19 epidemic. Plans to prevent and address violence against cisgender and trans women, especially those with heightened vulnerability that may be associated with living with HIV, are needed in public health planning for future pandemics.

Keywords: COVID-19; HIV; cisgender women; intimate partner violence; trans women.

PubMed Disclaimer

Figures

FIG. 1.
FIG. 1.
Study flowchart. Rio de Janeiro, Brazil, 2020.
FIG. 2.
FIG. 2.
Interconnections between Intimate Partner Violence according to types and gender identity during the COVID-19 pandemic in Rio de Janeiro, Brazil, 2020.

Similar articles

References

    1. Marshall KJ, Fowler DN, Walters ML, et al. . Interventions that address intimate partner violence and HIV among women: A systematic review. AIDS Behav 2018;22(10):3244–3263; doi: 10.1007/s10461-017-2020-2. - DOI - PMC - PubMed
    1. Peitzmeier SM, Malik M, Kattari SK, et al. . Intimate partner violence in transgender populations: Systematic review and meta-analysis of prevalence and correlates. Am J Public Health 2020;110(9):e1–e14; doi: 10.2105/AJPH.2020.305774. - DOI - PMC - PubMed
    1. Marques ES, Moraes CL de, Hasselmann MH, et al. . Violence against women, children, and adolescents during the COVID-19 pandemic: Overview, contributing factors, and mitigating measures. Cad Saude Publica 2020;36(4):e00074420; doi: 10.1590/0102-311x00074420. - DOI - PubMed
    1. Agüero JM. COVID-19 and the rise of intimate partner violence. World Dev 2021;137:105217; doi: 10.1016/j.worlddev.2020.105217. - DOI - PMC - PubMed
    1. Matoori S, Khurana B, Balcom MC, et al. . Addressing intimate partner violence during the COVID-19 pandemic and beyond: How radiologists can make a difference. Eur Radiol 2021;31(4):2126–2131; doi: 10.1007/s00330-020-07332-4. - DOI - PMC - PubMed

LinkOut - more resources